Skip to content

Effect of consuming fermented ginseng on improving nutritional anemia among females: A randomized controlled trial

Effect of consuming fermented ginseng on improving nutritional anemia among females: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090968
Enrollment
Unknown
Registered
2024-10-16
Start date
2024-10-20
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional anemia

Interventions

Intervention group:Oral administration of fermented ginseng product
Control group:Oral administration of a placebo with the same packaging, formulation, color, and odor as preparation but without active fermented ginseng ingredients

Sponsors

Medical College of Wuhan University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The hemoglobin concentration detected from blood sampling is =120g/L; 2. Female aged 18 to 80 years old; 3. Willing and able to adhere to the research requirements, especially taking the research product as recommended, avoiding any nutritional, medical, or other management methods for nutritional anemia and qi-blood deficiency syndrome during the study period, and maintaining dietary, sleep, and exercise habits throughout the study. Meeting each of the above inclusion criteria constitutes eligibility for inclusion.

Exclusion criteria

Exclusion criteria: 1. Currently undergoing treatment for nutritional anemia or qi-blood deficiency syndrome; 2. Have taken or are currently taking ginseng or ginseng preparations within the past month. 3. Have participated in other interventional trials within the past 3 months; 4. Are pregnant, lactating, or planning to conceive within the next 6 months; 5. Have undergone major surgery within the past 3 months, or have a clinically significant known (self-reported) medical history and/or clinically significant known (self-reported) conditions/disorders that, according to the investigator's judgment, may affect the study results or the subject's safety; 6. Any other exclusion criteria according to the investigator's judgment. Meeting any of the above exclusion criteria renders the individual ineligible for inclusion.

Design outcomes

Primary

MeasureTime frame
Hemoglobin concentration;

Secondary

MeasureTime frame
Syndrome score in traditional Chinese medicine;Skin health;Fasting glucose;Glycated hemoglobin;Total cholesterol ;High-density lipoprotein;Low-density lipoprotein;Triglyceride;Red blood cell count;Serum iron;Serum ferritin;Erythropoietin;Thrombopoietin;Mean corpuscular volume;Mean corpuscular hemoglobin;Mean corpuscular hemoglobin concentration;Serum total ginsenoside content;Serum concentration of rare ginsenosides;Richness of gut microbiota;Score of life quality;

Countries

China

Contacts

Public ContactRong Shuang

Medical College of Wuhan University of Science and Technology

rongshuangwust@yeah.net+86 185 7172 7264

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026